Physician profile
Perkin Shiu
NPI 1134375272
$45,016.71
in general payments reported to CMS, 2019-2025
55 companies · $8,720 in 2025
The $8,720 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,244 · 2020: $6,122 · 2021: $3,870 · 2022: $3,735 · 2023: $9,911 · 2024: $4,414 · 2025: $8,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $10K · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,464.00 |
| Food and Beverage | $10,481.88 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $9,083.27 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $8,419.30 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $6,300.76 | 2019-2025 | Watchman Access System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Biotronik INC. | $6,060.52 | 2019-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,887.83 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $1,020.00 | 2022-2025 | Optimizer, Optimizer |
| Aop Health US, LLC | $812.06 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $766.44 | 2019-2025 | |
| Amgen INC. | $758.17 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $733.34 | 2021-2025 | Wainua, Brilinta, Farxiga |
| Janssen Pharmaceuticals, INC | $594.45 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $543.86 | 2019-2023 | |
| Abbott Laboratories | $522.49 | 2019-2025 | Triclip, Amplatzer Amulet, Gallant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $515.12 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $504.29 | 2019-2021 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $435.22 | 2022-2025 | Verquvo, Winrevair |
| Elutia, INC. | $371.26 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $362.32 | 2022-2025 | |
| Itamar Medical INC | $313.20 | 2022-2025 | Watchpatone |
| Philips North America LLC | $268.43 | 2024-2025 | (5044) Mcot, Mcot |
| Heartflow, INC. | $262.44 | 2020-2025 | Ffrct |
| Cvrx, INC. | $188.32 | 2024-2025 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $181.31 | 2022-2024 | Opsumit, Uptravi |
| Atricure, INC. | $168.24 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Novo Nordisk INC | $164.92 | 2023 | Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $155.24 | 2023-2025 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $130.33 | 2019-2025 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $128.05 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $119.43 | 2024-2025 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $114.35 | 2024 | Arcalyst |
| Acera Surgical, INC. | $111.11 | 2024 | Restrata Wound Matrix |
| Bridgebio Pharma, INC. | $93.67 | 2025 | Attruby |
| Lilly USA, LLC | $89.87 | 2019-2025 | Mounjaro, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $82.10 | 2022 | |
| Daiichi Sankyo INC. | $77.82 | 2023 | Injectafer |
| Akcea Therapeutics, INC. | $77.18 | 2019-2020 | |
| Medtronic, INC. | $75.61 | 2021-2022 | |
| Ethicon US, LLC | $66.67 | 2020 | |
| Kci USA, INC. | $61.87 | 2020 | |
| Scpharmaceuticals INC. | $61.23 | 2025 | |
| Edwards Lifesciences Corporation | $56.20 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals, LTD. | $38.47 | 2023 | Arcalyst |
| Abiomed | $31.17 | 2024 | Impella |
| Bardy Diagnostics, INC. | $31.05 | 2020 | |
| Intuitive Surgical, INC. | $22.73 | 2024 | |
| Braemar Manufacturing, LLC | $18.98 | 2019 | |
| Lundbeck LLC | $18.72 | 2019 | |
| Avanos Medical | $18.52 | 2024 | On-Q* Pump and Accessories |
| Portola Pharmaceuticals, LLC | $18.10 | 2019 | |
| Kestra Medical Technology Services, INC. | $15.63 | 2022 | |
| Glaxosmithkline, LLC. | $14.11 | 2025 | Shingrix |
| Medtronic Vascular, INC. | $13.77 | 2019 | |
| Irhythm Technologies, INC. | $12.87 | 2019 | |
| Circassia INC. | $12.40 | 2019 | |
| Davol INC. | $11.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perkin Shiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.